Satyan Chintawar Email and Phone Number
Satyan Chintawar personal email
- Valid
Current drug discovery paradigm is ineffective with more than 90% of drugs failing to progress through all clinical stages of drug development. Principal reason for this high attrition rate is the excessive reliance on cellular models which are clinically less relevant. Nobel prize winning cellular reprogramming technology has the potential to transform the drug discovery landscape by employing patient derived induced pluripotent stem cells (iPSC) at the earliest stages, thus drastically reducing clinical trial failure. However, generating iPSCs is labour intensive and costly, which has been a major bottleneck in realising its full potential. We at Oxford StemTech have developed a novel method of producing high quality iPSC lines at scale and at a fraction of cost currently possible. iPSC technologies if combined with other technologies such as gene editing, organoids and artificial intelligence can truly revolutionize drug discovery, bringing precision medicine in the clinic earlier than previously imagined. Join the purpose!
Oxford Stemtech
View- Website:
- oxfordstemtech.com
- Employees:
- 7
-
Coo And Co-FounderOxford Stemtech Sep 2020 - PresentCurrent drug discovery paradigm is ineffective with more than 90% of drugs failing to progress through all clinical stages of drug development. Principal reason for this high attrition rate is the excessive reliance on cellular models which are clinically less relevant. Nobel prize winning cellular reprogramming technology has the potential to transform the drug discovery landscape by employing patient derived induced pluripotent stem cells (iPSC) at the earliest stages, thus drastically reducing clinical trial failure. However, generating iPSCs is labour intensive and costly, which has been a major bottleneck in realising its full potential. We at Oxford StemTech have developed a novel method of producing high quality iPSC lines at scale and at a fraction of cost currently possible. iPSC technologies if combined with other technologies such as gene editing, organoids and artificial intelligence can truly revolutionize drug discovery, bringing precision medicine in the clinic earlier than previously imagined. Join the purpose! -
Senior Researcher (Osi)University Of Oxford Jul 2017 - Sep 2020Oxford, Oxfordshire, GbHuman-centric drug discovery to construct cell-based phenotypic assays using patient-specific induced pluripotent stem cells and establish a high throughput screening platform to identify a novel target for migraine. -
Postdoctoral Researcher (Imi-Stembancc)University Of Oxford May 2013 - May 2017Establishing iPSC-based cellular models for disease modelling and drug screening applications for neurological diseasesDesign and execute experiments for multiple projectsTraining multiple laboratory staffResponsible for project research budget and planning submissions for grant funding
-
Postdoctoral Researcher (Imi-Efacts)Université Libre De Bruxelles Nov 2009 - Apr 2013Ixelles, Bruxelles, BeLead in setting up and establishing human iPSC technology. Molecular and physiological characterization of iPS cell-derived neurons and glial cells to establish cellular models of neurological diseases. iPS cell grafts into animal models of neurological diseases as experimental therapies. -
Research InternUniversité De Montréal Apr 2005 - Feb 2006Montréal, Qc, CaInvestigate interaction of neural stem cells with human blood-brain barrier in an in vitro model -
Research InternUniversità Degli Studi Di Milano-Bicocca Sep 2003 - Jun 2004Milan, Lombardy, ItSVZ-derived neural stem cell culture and transplantation -
Business OfficerZydus Cadila 2000 - 2001Ahmedabad, Gujarat, InLink between medical, healthcare professionals and pharmaceutical companyPromoting product awarenessTrack competitor activityReviewing sales performanceWriting reports and other literature -
LecturerUniversity Of Pune 1999 - 2000InTraining undergraduate pharmacy students using teaching methods of lectures, seminars, tutorials, practical demonstrationsTo participate in departmental seminars aimed at sharing research outcomes and building interdisciplinary collaboration within and outside the departmentDelivering conference presentations
Satyan Chintawar Skills
Satyan Chintawar Education Details
-
Université Libre De BruxellesNeuroscience -
Savitribai Phule Pune UniversityPharmacology -
Nagpur UniversityPharmaceutical Chemistry
Frequently Asked Questions about Satyan Chintawar
What company does Satyan Chintawar work for?
Satyan Chintawar works for Oxford Stemtech
What is Satyan Chintawar's role at the current company?
Satyan Chintawar's current role is COO and Co-Founder at Oxford StemTech.
What is Satyan Chintawar's email address?
Satyan Chintawar's email address is sa****@****ail.com
What schools did Satyan Chintawar attend?
Satyan Chintawar attended Université Libre De Bruxelles, Savitribai Phule Pune University, Nagpur University.
What are some of Satyan Chintawar's interests?
Satyan Chintawar has interest in Social Services, Children, Environment, Education, Induced Pluripotent Stem Cell Biology, Science And Technology, Pluripotent Stem Cell Biology, Health.
What skills is Satyan Chintawar known for?
Satyan Chintawar has skills like Stem Cells, Ipsc Generation, Cell Culture, Neurovascular Differentiation, Cellular Reprogramming, Rna Seq, Atac Seq, Human Brain Primary Culture, Molecular Biology, Cell Biology, Life Sciences, Pharmacology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial